Viewing Study NCT03470350


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-03-05 @ 8:51 AM
Study NCT ID: NCT03470350
Status: WITHDRAWN
Last Update Posted: 2019-07-24
First Post: 2018-02-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
Sponsor: The Netherlands Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: M16TGA
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None INDUSTRY View
None NETWORK View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View
None OTHER_GOV View
None OTHER View